Names | |
---|---|
Preferred IUPAC name
2-Amino-1-(2,5-dimethoxy-4-methylphenyl)ethan-1-ol | |
Other names
4-Methyl-2,5-dimethoxy-beta-hydroxyphenethylamine
2-(4-Methyl-2,5-dimethoxyphenyl)ethan-beta-hydroxyamine | |
Identifiers | |
3D model (
JSmol)
|
|
ChemSpider | |
PubChem
CID
|
|
UNII | |
CompTox Dashboard (
EPA)
|
|
| |
| |
Properties | |
C11H17NO3 | |
Molar mass | 211.261 g·mol−1 |
Except where otherwise noted, data are given for materials in their
standard state (at 25 °C [77 °F], 100 kPa).
|
BOHD (4-methyl-2,5-dimethoxy-beta-hydroxyphenethylamine) is a lesser-known psychedelic drug. It is the beta- hydroxy derivative of 2C-D. BOHD was first synthesized by Alexander Shulgin. In his book PiHKAL, the minimum dosage is listed as 50 mg, and the duration unknown. [1] BOHD produces a marked drop in blood pressure. [1] Very little data exists about the pharmacological properties, metabolism, and toxicity of BOHD.
This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act. [2]
In the U.S., this substance is a Schedule 1 isomer of Mescaline.
Names | |
---|---|
Preferred IUPAC name
2-Amino-1-(2,5-dimethoxy-4-methylphenyl)ethan-1-ol | |
Other names
4-Methyl-2,5-dimethoxy-beta-hydroxyphenethylamine
2-(4-Methyl-2,5-dimethoxyphenyl)ethan-beta-hydroxyamine | |
Identifiers | |
3D model (
JSmol)
|
|
ChemSpider | |
PubChem
CID
|
|
UNII | |
CompTox Dashboard (
EPA)
|
|
| |
| |
Properties | |
C11H17NO3 | |
Molar mass | 211.261 g·mol−1 |
Except where otherwise noted, data are given for materials in their
standard state (at 25 °C [77 °F], 100 kPa).
|
BOHD (4-methyl-2,5-dimethoxy-beta-hydroxyphenethylamine) is a lesser-known psychedelic drug. It is the beta- hydroxy derivative of 2C-D. BOHD was first synthesized by Alexander Shulgin. In his book PiHKAL, the minimum dosage is listed as 50 mg, and the duration unknown. [1] BOHD produces a marked drop in blood pressure. [1] Very little data exists about the pharmacological properties, metabolism, and toxicity of BOHD.
This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act. [2]
In the U.S., this substance is a Schedule 1 isomer of Mescaline.